THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE PURCHASE ORDER CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES . The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division - West (HCD-W), Echo Branch intends to negotiate and award a firm-fixed price purchase order (PO) contract for the provision of all services, materials, and equipment necessary to provide required Reagents and Maintenance Service for Flow Cytometry Instruments for Madigan Armey Medical Center, Pathology Department in accordance with Federal Acquisition Regulation (FAR) 6.302-1 Sole Source acquisitions and FAR RFO 12.102 (a) only one source being available to meet the Government’s needs, to: Beckman Coulter, Inc 250 Kraemer Blvd Brea, CA 92821-6232 UEI: Z4DRFM3LMJB8 CAGE: 80740 The North American Industry Classification System (NAICS) code for this requirement is 325413 – In-Vitro Diagnostic Substance Manufacturing; the business size standard is 1,250 (# of employees). The Product Service Code (PSC) is 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits, and Sets. The requirement is for Reagents and Maintenance Service contract for Madigan Armey Medical Center. The items being purchased are reagents and testing materials necessary to perform flow cytometry testing using Government-owned Navios 10 analyzer and TQ Prep workstation, as well as maintenance, service, and training on the analyzers for the Department of Pathology, Core Laboratory Services at Madigan Army Medical Center, Joint Base Lewis-McChord, WA. Flow cytometry is a critical tool used to specifically characterize and identify types of white blood cells, and any alteration in that cell type that may be responsible for the onset of infectious diseases, autoimmune disorders or immunodeficiencies. Requirement Description Product Number Quantity Anti-Kappa-FITC (Goat Polyclonal), 2ml ASR C15623 2 Anti-Lambda-PE (Goat Polyclonal), 2ml ASR C15189 2 FMC7-FITC, 1ML, ASR IM1364U 2 MYELORPEROXIDASE-RPE, 2ML, ASR IM3455U 2 7-AAD Viability Dye 150t CE A07704 4 CD1a-APC , 1ML, ASR IM3645 2 Anti-TdT (POOL)-FITC, 1ML, ASR IM3524U 2 CD2-Pacific Blue, 0.5ML ASR B09685 2 CD3-ECD, 1ML, ASR IM2705U 2 CD3-FITC, 2ML, ASR IM1281U 2 CD4-APC-Alexa Fluor 700, 0.5ML ASR B10824 2 CD5-PC5.5, 0.5ML ASR A70203 2 CD7-PC7, 1ML ASR A46526 2 CD10-PC7, 1ML ASR A46527 2 CD11c-APCA700, 50t, ASR B43304 2 CD14-PC7, 1ML ASR A22331 2 CD16-APC, 0.5ML ASR B00845 2 CD19-APC, 1ML, ASR IM2470U 4 CD20-ECD, 1ML, ASR IM3607U 4 CD22-RPE, 2ML, ASR IM1835U 2 CD23-RPE, 2 ML ASR A33099 2 CD25-APC-Alexa Fluor 750, 0.5ML ASR B13979 2 CD26-RPE, 2ML, ASR IM2724 2 CD30-APC, 0.5ML ASR A87939 2 CD33-PC5.5, 0.5ML ASR A70198 2 CD34-APC-Alexa Fluor 750, 0.5ML ASR A89309 2 CD38-APC-Alexa Fluor 700, 0.5ML ASR B23489 2 CD45-Krome Orange, 1ML, AS A96416 4 CD56-PC7, 1ML ASR A51078 2 CD81-Pacific Blue, 0.5ML ASR B19717 2 CD79a-PC5.5, 50t, ASR B42018 2 CD103-FITC, 2ML, ASR IM1856U 2 CD117-ECD, 0.5ML ASR B38307 2 CD123-PC5.5, 0.5ML ASR B20022 2 CD138-PC5.5,0.5ML ASR A98835 2 CD45-FITC/CD56-PE/CD19-ECD/CD3-PC5 6607073 8 TETRA 45/4/8/3 6607013 8 FP,FLOW CHECK PRO IVD 3 X 10 ML KIT A63493 7 ISOFLOW(TM) EPICS SHEATH FL,10 8546859 20 FP, FLOW SET PRO IVD 3 X 10 ML KIT A63492 7 IMMUNO-TROL Low Cells 6607098 6 IMMUNO-TROL Cells 6607077 6 IntraPrep Permeabilization Reagent 50t CE A07802 2 ClearLLab 10C B Cell Tube B96805 15 ClearLLab 10C T Cell Tube B96806 15 ClearLLab 10C M1 Cell Tube B96807 6 ClearLLab 10C M2 Cell Tube B96808 6 PT Navios 3L 10C Service Contract B89707 1 CD57-FITC, 2ML, ASR IM0466U 2 IMMUNOPREP Reagent System 7546999 12 CD8-Pacific Blue, 0.5ML ASR A82791 2 Delivery Location: MADIGAN ARMY MEDICAL CENTER Bldg. 9040A Rm. G 3803 Tacoma, 98431 Delivery: On or before: 9/30/2027 Based on market research and previous acquisition history, it has been determined that Beckman Coulter, Inc is the only source that can meet the Government’s specialized requirement. This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed six (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order. If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to Jason Willey at
[email protected] and Tracy M. Robinson at
[email protected]. The closing date for challenges is no later than 10:00 a.m. (Pacific Time), 1 June 2026 NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.